Company News_Kangchuanji Pharmatech-Brand pharmaceutical enterprise

Recent developments to share with you

Quality is the lifeline of an enterprise – its core and soul.

Quality is the lifeline of an enterprise – its core and soul. To further standardize our R&D processes, effectively manage risks, and establish standardized operations and management practices, Nanjing Kangchuanji Pharmaceutical Technology Co., Ltd. passed the ISO 9001 Quality Management System (CNAS) certification in January 2025.

2025-01-26

View Detail

CDMO One-Stop Services for the Full Drug R&D and Manufacturing Lifecycle – Kangchuanji's Successful Participation in the Nanjing QianTuHui Conference

On July 18-19, the 88th Pharmaceutical QianTuHui Conference & National New Drug R&D and Investment M&A Summit was held at Nanjing Fengda International Hotel. Kangchuanji was invited to attend and set up a booth (Booth No. B02).

2024-07-21

View Detail

Good News! Kangchuanji Helps Partner Achieve China's First Generic Drug Consistency Evaluation for Co-Trimoxazole Injection

According to the drug approval information released by NMPA, the Co-Trimoxazole Injection (specification: 5ml containing sulfamethoxazole 0.4g and trimethoprim 80mg) manufactured by Nanjing Jinling Pharmaceutical Factory of Jinling Pharmaceutical Co., Ltd. has passed the national generic drug quality and efficacy consistency evaluation (referred to as "consistency evaluation"), becoming the first manufacturer in China to have this intravenous formulation approved through the consistency evaluation. Kangchuanji provided R&D-related services for this product.

2024-08-21

View Detail

Good News! Kangchuanji Helps Partner Achieve China's First Approval for Olmesartan Medoxomil Orally Disintegrating Tablets

According to the drug approval information released by NMPA, Guangzhou Yipinhong Pharmaceutical Co., Ltd. has obtained approval for its Olmesartan Medoxomil Orally Disintegrating Tablets. This product is the first generic version and the first to pass consistency evaluation in China. Kangchuanji provided services for this product.

2024-08-19

View Detail

Jiuzhou Pharmaceutical Included in the FTSE4Good Index Series for the First Time

Recently, FTSE Russell confirmed that Zhejiang Jiuzhou Pharmaceutical Co., Ltd. has been independently assessed against the FTSE4Good criteria and has met the requirements to become a constituent of the FTSE4Good Index Series.

2024-08-19

View Detail

< 1 2 3 4 5 >

Please contact us for more detailed information.

Kangchuanji Pharmatech looks forward to working with you and jointly creating a bright future!

Nanjing Kangchuanji Pharmatech Co., Ltd.

Contact Us：18020149597（HR）
Recruitment Email:recruit@kcjpharma.com
Address: 2nd Floor, Building 5, No.199 Wenfang Road, Jiangning District, Nanjing, Jiangsu Province, China（Jiangning High-tech Park）

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

南京康川济医药科技有限公司

Recent developments to share with you

COOKIES

COOKIES